Literature DB >> 6928612

Antisickling activity of amino acid benzyl esters.

M Gorecki, C T Acquaye, M Wilchek, J R Votano, A Rich.   

Abstract

The sickling of homozygous sickel cells upon deoxygenation is inhibited in the presence of 3 mM L-phenylalanine benzyl ester (Phe-OBzl) or benzyl esters of other aromatic or hydrophobic amino acids. Phe-OBzl was found to permeate into erythrocytes rapidly, and the deoxygenated cells maintained considerable flexibility as measured by their ability to pass through 3-micron pores. The osmotic fragility of the cells was unchanged and the oxygen dissociation curve was shifted slightly from a 50% saturation values of 28.5 mm Hg to 31.0 mm Hg. At lower concentrations of Phe-OBzl some antisickling activity was seen. The Phe-OBzl antisickling activity may involve both binding to deoxyhemoglobin S and modification of the erythrocyte membrane. This class of compounds has considerable potential as therapeutic agents for the treatment of sickle cell disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6928612      PMCID: PMC348232          DOI: 10.1073/pnas.77.1.181

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Studies on the destruction of red blood cells; irreversibly sickled erythrocytes; their experimental production in vitro.

Authors:  S C SHEN; E M FLEMING; W B CASTLE
Journal:  Blood       Date:  1949-05       Impact factor: 22.113

Review 2.  The membrane actions of anesthetics and tranquilizers.

Authors:  P Seeman
Journal:  Pharmacol Rev       Date:  1972-12       Impact factor: 25.468

3.  Antisickling effects of zinc.

Authors:  G J Brewer; F J Oelshlegel
Journal:  Biochem Biophys Res Commun       Date:  1974-06-04       Impact factor: 3.575

4.  Restoration of the deformability of "irreversibly" sickled cells by procaine hydrochloride.

Authors:  R Baker; D Powars; L J Haywood
Journal:  Biochem Biophys Res Commun       Date:  1974-07-24       Impact factor: 3.575

5.  Steroid hormones in sickle-cell disease.

Authors:  W A Isaacs; F G Hayhoe
Journal:  Nature       Date:  1967-09-09       Impact factor: 49.962

6.  Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions.

Authors:  M P Sheetz; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

7.  Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.

Authors:  A Cerami; J M Manning
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

8.  Inhibition of erythrocyte sickling in vitro by DL-glyceraldehyde.

Authors:  A M Nigen; J M Manning
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

9.  Dimethyl adipimidate: a new antisickling agent.

Authors:  B H Lubin; V Pena; W C Mentzer; E Bymun; T B Bradley; L Packer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

10.  Patterns of nonelectrolyte permeability in human red blood cell membrane.

Authors:  P Naccache; R I Sha'afi
Journal:  J Gen Physiol       Date:  1973-12       Impact factor: 4.086

View more
  2 in total

1.  Physiological and x-ray studies of potential antisickling agents.

Authors:  D J Abraham; M F Perutz; S E Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

2.  Potential use of biaromatic L-phenylalanyl derivatives as therapeutic agents in the treatment of sickle cell disease.

Authors:  J R Votano; J Altman; M Wilchek; M Gorecki; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.